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Abstract
Background
Visceral leishmaniasis (VL) is hypoendemic in the Mediterranean region, where it is caused
by the protozoan Leishmania infantum. An effective vaccine for humans is not yet available
and the severe side-effects of the drugs in clinical use, linked to the parenteral administra-
tion route of most of them, are significant concerns of the current leishmanicidal medicines.
New drugs are desperately needed to treat VL and phenotype-based High Throughput
Screenings (HTS) appear to be suitable to achieve this goal in the coming years.
Methodology/Principal findings
We generated two infrared fluorescent L. infantum strains, which stably overexpress the
IFP 1.4 and iRFP reporter genes and performed comparative studies of their biophotonic
properties at both promastigote and amastigote stages. To improve the fluorescence emis-
sion of the selected reporter in intracellular amastigotes, we engineered distinct constructs
by introducing regulatory sequences of differentially-expressed genes (A2, AMASTIN and
HSP70 II). The final strain that carries the iRFP gene under the control of the L. infantum
HSP70 II downstream region (DSR), was employed to perform a phenotypic screening of a
collection of small molecules by using ex vivo splenocytes from infrared-infected BALB/c
mice. In order to further investigate the usefulness of this infrared strain, we monitored an
in vivo infection by imaging BALB/c mice in a time-course study of 20 weeks.
Conclusions/Significance
The near-infrared fluorescent L. infantum strain represents an important step forward in bioi-
maging research of VL, providing a robust model of phenotypic screening suitable for HTS
of small molecule collections in the mammalian parasite stage. Additionally, HSP70 II+L.
infantum strain permitted for the first time to monitor an in vivo infection of VL. This finding
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accelerates the possibility of testing new drugs in preclinical in vivo studies, thus supporting
the urgent and challenging drug discovery program against this parasitic disease.
Author Summary
Visceral leishmaniasis (VL), caused by Leishmania infantum or L. donovani, is still one of
the most threatening diseases affecting poor people in developing countries, with a fatality
rate as high as 100% in two years in infected and untreated people. With no vaccine avail-
able and ineffective and toxic chemotherapy, the search for new potential drugs that accel-
erate the urgent drug discovery process are highly needed. A novel technology that
addresses this important issue has been developed, by performing High Throughput
Screening (HTS) assays in 384-well plates format in combination with an infrared L. infan-
tum-expressing strain. The system was further validated to identify active compounds
against VL in an ex vivo splenic culture. In addition, in vivo non-invasive imaging of the
visceral infection in BALB/c mice was achieved for the first time by using transgenic fluo-
rescent parasites. These findings open up the possibility of testing vast amounts of poten-
tial compounds and allow in vivo screening of drug candidates against this severe parasitic
disease in an attempt to speed up the vital drug discovery program.
Introduction
Neglected Tropical Diseases (NTDs) are severe scourges that affect the less protected layer of
the poorest population of low-income countries [1, 2]. Their neglected consideration implies a
poor attention by most of the actors involved in their eradication including Pharma Industries,
which are more concerned about those diseases affecting people from more developed coun-
tries [3]. The fight against these diseases is mainly based on preventive measures, but when the
latter fails and a sudden outbreak emerges, no effective vaccines exist and treatment is based on
the administration of drugs [4]. However, due to the low investments in R & D to develop new
compounds most of them are outdated, toxic in many cases, full of undesirable side effects and
their route of administration requires hospitalization [5, 6]. All these are major drawbacks for
the frequently overwhelmed health systems of these countries.
Recent drug discovery programs sponsored by public or private initiatives pursue a crushing
defeat of major NTDs during this decade. Visceral leishmaniasis (VL) is one of the diseases
that accomplish all the conditions to be a NTD. Unfortunately, no effective vaccine candidates,
either prophylactic or preventive, are under clinical trials [7], the treatment is still mainly
based on old-fashioned antimony derivatives and the administration route of these drugs is
parenteral. To overcome these gaps, several Big Pharma companies have made available to aca-
demic researchers and supranational institutions myriads of small molecules to be tested on
Leishmania on recently developed High Throughput target-based and target-free Screenings
platforms (HTS) [8, 9]. High Content Screening (HCS) image-based readouts using confocal
microscopy, or genetically modified parasites expressing easily detectable reporters are in the
pipeline of target-free (phenotypic) in vitro screenings [10, 11]. The use of transgenic light-
emitting parasites has an additional advantage since they permit a further scaling up to in vivo
preclinical trials using rodent models of both visceral and cutaneous infections for monitoring
parasite loads by means of bioimaging devices [12].
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So far, luminescent transgenic parasites that express genes encoding the firefly or Renilla sp.
luciferases are the only systems that permit a rapid readout in vitro under HTS conditions and
the assessment of parasitic burdens in internal organs of living mice [13–15]. The major pitfall
of luminescence is the need of adding a light-emitting substrate–luciferin or coelenterazine–
that is time-consuming and significantly increases the cost of the analysis. For this reason, stan-
dard fluorescent proteins are more suitable for in vitro assays [16]. There are many drug
screening systems using GFP, RFP or mCherry-transformed parasites that have been useful to
evaluate libraries of compounds on Leishmania promastigotes and amastigotes [17–19]. More-
over, the appraisal of in vivo infections by using these genetically-modified strains is currently
limited to cutaneous leishmaniasis (CL) models. However, fluorescence emission in the visible
spectrum has low tissue penetration to be recorded by the standard optical imaging platforms
[20]. This drawback has been overcome by the arising of a new developed protein (IFP 1.4)
from the bacteriophytochrome of Deinococcus radiodurans, whose emission in the near-
infrared region prevents any background interference derived from organs or tissues [21]. This
protein has been successfully used to image the in vivo infection of the adenovirus serotype 5
(Ad5) that specifically infects the mouse liver in vivo. More recently, a new-engineered infrared
fluorescent protein (iRFP) from the photosynthetic bacterium Rhodopseudomonas palustris
showed a clear superiority over IFP 1.4 to evidence the viral load of Ad5 in mouse liver [22].
In this report, we have established for the first time a platform based on the comparative
analysis of IFP 1.4- and iRFP- transfected L. infantum BCN 150 amastigote-infecting spleno-
cytes ex vivo to perform phenotypic screenings with several drug collections of small molecules.
In addition, the latter strain was used to monitor the development of an in vivo infection of VL,
showing the higher tissue penetration of iRFP over IFP 1.4, which represents a useful tool to as-
sess the parasite load by non-intrusive bioimaging techniques.
Methods
The animal research described in this manuscript complies with Spanish Act (RD 53/2013)
and European Union Legislation (2010/63/UE). The used protocols were approved by the Ani-
mal Care Committee of the University of León (Spain), project license number (PI12/00104).
Mice and parasites
Female BALB/c mice (6–8 weeks old) were obtained from Harlan Interfauna Iberica SA (Barce-
lona, Spain) and housed in specific-pathogen-free facilities for this study. L. infantum (strain
MCAN/ES/96/BCN 150) promastigotes were obtained from J.M. Requena (Centro de Biología
Molecular Severo Ochoa, Madrid, Spain). Parasites were routinely cultured at 26ºC in M199
medium supplemented with 25 mMHEPES pH 6.9, 10 mM glutamine, 7.6 mM hemin,
0.1 mM adenosine, 0.01 mM folic acid, 1x RPMI 1640 vitamin mix (Sigma), 10% (v/v) heat-
inactivated foetal calf serum (FCS) and antibiotic cocktail (50 U/ml penicillin, 50 μg/ml
streptomycin).
Generation of near-infrared L. infantum strains
The 987-bp IFP1.4 coding region was amplified by PCR from pENTR1A vector, a kindly gift
from Dr. Roger Y. Tsien, Departments of Pharmacology and Chemistry & Biochemistry,
UCSD (USA). The oligonucleotides used as primers (RBF696 and RBF687 in Table 1) intro-
duced NcoI-NotI as restriction sites. The 948-bp iRFP coding region was digested with BglII
and NotI from pShuttle CMV-iRFP vector obtained from Dr. Vladishlav V. Verkhusha
−Department of Anatomy and Structural Biology and Gruss-Lipper Biophotonics Center, Al-
bert Einstein College of Medicine, Bronx, New York (USA). The successful cloning of these
Infrared Fluorescent Imaging in Visceral Leishmaniasis
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ORFs in pLEXSY-hyg2 (Jena Bioscience) yielded pLEXSY-IFP1.4-HYG and pLEXSY-iRF-
P-HYG vectors, respectively. Parasites expressing IFP1.4 and iRFP reporters were obtained
after electroporation of L. infantum BCN150 promastigotes with the linear SwaI-targeting frag-
ment obtained from the above described vectors. Subsequent plating on semisolid media con-
taining 200 μg/ml hygromycin B, allowed the isolation of individual clones that were
subcultured in liquid media with antibiotic pressure. Correct integration of each fragment into
the 18S rRNA locus of the resulting clones (IFP 1.4+L. infantum and iRFP+L. infantum) was
confirmed by PCR amplification analysis, using appropriate primers (Table 1).
To achieve a higher stability of the reporter mRNAs 3’-untranslated regions (3’-UTRs) and
intergenic regions (IR) were also included. For this purpose, three fragments derived from
L. donovani A2 (LinJ.22.0670) (3400 bp) [23], L. infantum AMASTIN (LinJ.34.1010) (1200 bp)
[24] and HSP70-II (LinJ.28.3060) (1600 bp) [25], were amplified using forward primers, which
introduced a 5’-NotI site, and reverse primers that introduced a 3’-XbaI site (Table 1). Each
amplicon was NotI/XbaI-digested and ligated into the parental construct pLEXSY-iRFP-HYG
previously cut with the same enzymes to remove the urt2, thus yielding pLEXSY-iRFP-A2-
HYG, pLEXSY-iRFP-AMASTIN-HYG and pLEXSY-iRFP-HSP70-HYG, respectively. Electro-
poration and semisolid selection, as well as correct integration, were done as described above.
Several clones from each electroporation were grown in liquid medium in the presence of anti-
biotic selection and those clones with higher infrared fluorescent emission were selected after
flow cytometry analysis (Cyan ADP, Dako). In addition, each L. infantummodified strain was
used to infect mice in order to recover the lost infectivity after cloning and plating. We will
hereafter refer to these strains as A2+L.infantum, AMASTIN+L.infantum and HSP70+L.
infantum.
In vitro infections
The human acute leukemia monocyte cell line (THP-1, ATCC TIB-202), was cultivated in
RPMI medium supplemented with 10% heat-inactivated FCS and 1% streptomycin/penicillin
at 37ºC and 5% CO2. The cultures were diluted every 3 or 4 days to maintain the cell density
between 105 cells/ml and 8 x 105 cells/ml. THP-1 cells at 5 x 105 cells/ml were differentiated
Table 1. Oligonucleotides used in this work.
Oligo No. Sequencea,b Purposedc
RBF696 ccgctcgagCCATGGCCACCATGGCTCGGGACCCTCTGCC IFP 1.4 F
RBF697 ataagaatGCGGCCGCTCATTTATACAGCTCGTCCATTCC IFP 1.4 R
RBF843 ATGGCGGAAGGATCCGTCGC iRFP F
RBF844 TCACTCTTCCATCACGCCGATC iRFP R
RBF674 ataagaatGCGGCCGC ATCGCCCGAGTGCTGTGAAAC 3’ HSP70 F
RBF675 gcTCTAGAAGATCTTGACGGGTGAATGTGTTT 3’ HSP70 R
RBF774 gcTCTAGACCACCATGACCGAGTACAAGCCCACG PAC F
RBF775 ggACTAGTTCAGGCACCGGGCTTGCGG PAC R
RBF847 ataagaatGCGGCCGCGGCTCGGCGTCCGCTTTCC 3’A2 F
RBF848 ggACTAGTGGTTATGCTTATGTGGGCGTAC 3’A2 R
RBF861 ataagaatGCGGCCGCGTGGCTGTCTAACTACACTTTCG 3’Amastin F
RBF862 ggACTAGTGCGGCTCGCCAGTGTAGCAG 3’Amastin R
aUnderlined sequence indicates restriction site.
bBold sequence indicates optimized translation initiation sequence.
cOrientation of primers: F, forward; R, reverse.
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with 50 ng/ml of phorbol 12-myristate 13-acetate (PMA) for 48 h at 37ºC and 5% CO2. Station-
ary promastigotes of each infrared strain (5–6 day cultures) freshly transformed from lesion
amastigotes were added to differentiated-macrophages at 10:1 ratio for 24 h at 37ºC. Then, the
parasites that have not been internalized were removed by washing with phosphate-buffered
saline (PBS). Intracellular infrared signal was analyzed after 72 h post-infection by flow cytom-
etry (Cyan ADP, Dako).
In vivo infections, spleen cell proliferation and parasite quantification
Female BALB/c mice (5 animals per group) were injected intraperitoneally with either 107 in-
fective-stage metacyclic promastigotes of L. infantum BCN 150 wild type, IFP 1.4+, iRFP+,
A2+, AMASTIN+ and HSP70+L. infantum strains. Metacyclic parasites were purified from
stationary cells freshly transformed from lesion amastigotes by negative selection with peanut
agglutinin [26]. At different times post-infection, five animals were euthanized and their
spleens and livers were aseptically recovered, washed in cold PBS and placed in Petri dishes.
Spleens were used for evaluating the proliferative response of spleen cells after concanavalin A
(Con A) addition. Briefly, small pieces were obtaining by using a scalpel. In order to obtain a
single cell suspension, the tissue was incubated with 2 ml of collagenase D (Roche) at 2 mg/ml
of buffer (10 mMHEPES pH 7.4, 150 mMNaCl, 5 MmKCl, 1 mMMgCl2, 1.8 mM CaCl2) for
20 min at 37ºC. The cell suspension and remaining tissue fragments were gently passed
through a 100 μm-cell strainer to remove the tissue fragments. After erythrocyte lysis, spleno-
cytes were washed 3x with PBS by centrifugation (500 x g for 7 min at 4ºC). Splenocytes were
seeded at a density of 2 x 105 cells/well in 96-wells plates in RPMI medium, 20% FCS, 1 mM so-
dium pyruvate, 1x RPMI vitamins, 10 mMHEPES and 100 U/ml penicillin and 100 μg/ml
streptomycin supplemented with 50 μM 2-mercaptoethanol. Cells were cultured in medium
alone (control) or stimulated with Con A (5 mg/ml) for 3 days. One μCi of [3H]-thymidine was
added for the final 16 to 18 h of the culture. Subsequently, cells were washed, lysed and [3H]-
thymidine incorporation was measured onto glass fiber filters for scintillation counting. The
splenocyte stimulation index was determined by dividing the cpm of Con A-stimulated and
non-stimulated splenocytes [27].
The total number of living parasites in the organs was calculated from single-cell suspensions
that were obtained by homogenization of the tissue through a wire mesh. Briefly, liver and
spleen homogenates (100 mg/ml) were serially diluted in complete Schneider’s medium and dis-
tributed in 96-well plates at 26ºC. After 10 days, each well was examined and categorized as pos-
itive or negative according to the presence of viable promastigotes. The number of parasites was
calculated as follows: Limit Dilution Assay Units (LDAU) = (geometric mean of titer from qua-
druplicate cultures) x (reciprocal fraction of the homogenized organ added to the first well). The
titer was the reciprocal of the last dilution in which parasites were observed [28].
Extraction of intracellular parasites from in vitro and ex vivo infections
and their further processing
Intracellular amastigotes were purified from infected THP-1 macrophages and from spleen tis-
sues in order to evaluate the infrared emission of intracellular parasites and for developing a
standard curve up to the fifth week post-infection (5 wpi) in mice. On the one hand, 72 h post-
infection THP-1 macrophages were washed twice with cold PBS, and scraped off using a rubber
policeman. On the other hand, the spleens at different time points were collected and a spleno-
cyte suspension was obtained by passing the spleen through a wire mesh. Both cellular suspen-
sions from in vitro infections and from splenocytes were disrupted by passing sequentially
through 27G1/2 and 30G1/2 needles, and polycarbonate membrane filters having pore sizes of
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8 μm, 5 μm and 3 μm (Isopore, Millipore) [29]. Released amastigotes (free of host cells), were
washed twice with PBS (3000 x g for 10 min at 4ºC) and counted by direct microscopy. The
standard curves were developed using microscopic quantification of amastigotes and the corre-
sponding infrared signal at 2-fold serial dilutions.
Development of the ex vivo splenic explant culture
Several parameters were included in the development of the explant culture. i) Parasite infec-
tion rate is not equal in all animals from the same batch, thus in order to normalize the ex vivo
culture, only spleens with weights 0.7 g were selected to prepare the ex vivo explants. ii) The
starting cell density was adjusted in terms of fluorescence emission in a wide range of arbitrary
units (0.25, 0.5, 1.0, and 2.0 x 105 AU). Since we intend to evaluate the drug inhibition in ex
vivo cultures for at least 4 days, the initial number of AU that matched this condition was cho-
sen. iii) Discrimination between drug-treated and untreated control cells was assessed by add-
ing amphotericin B (AmpB) to the explants cultures. iv) To prevent the edge effect caused by
evaporation from outer wells in assays with multi-day incubations, the top and bottom rows as
well as the first and last columns were filled with ddH2O. In addition, the positive and negative
controls were symmetrically distributed through the columns [30].
Screening of compound collections
A total of 298 compounds belonged to three distinct collections including i) indenoisoquino-
lines obtained from Dr. Mark S. Cushman, Department of Medicinal Chemistry and Molecular
Pharmacology (Purdue University, Indiana, USA.); ii) podophylotoxin and quinones were a
kindly gift from Dr. Arturo San Feliciano, Deparment of Química Farmacéutica (Universidad
de Salamanca, Spain) and iii) carbolins obtained from Dr. Sankaran Murugeshan, Department
of Pharmacy, (Birla Institute of Technology & Science, Pilani, India). Stock solutions consisted
of test compound at a concentration of 200 μM in 20% DMSO. The 200 μMmaster plates were
further diluted by transferring aliquots of 5 μl into black 384-well plates with clear bottom con-
taining 45 μl of culture medium. The final concentration of DMSO in both assay and control
wells not exceeded 1% (v/v). Splenocytes obtained from infected mice (50 μl), were added to
Testing Plates (containing the compounds to be test at single 10 μM concentration) and Con-
trol Plates (containing positive and negative controls). The plates were incubated at 37ºC and
5% CO2 and at 0, 24, 48 and 72 h the infrared signal was recorded using the Odyssey infrared
system (LI-COR, USA). The anti-leishmanial reference drugs were amphotericin B, miltefo-
sine, and paromomycin sulfate.
The antileishmanial effect of the compounds was calculated as the percentage inhibition in re-
lation to AmpB and DMSO as follows: (mean of 1%DMSO–Experimental Value) / (mean of 1%
DMSO–mean of AmpBEC100) x 100. The positive control (10 μMAmpB), and the negative con-
trol (1% DMSO), placed in columns 2 and 23, were included in all Testing Plates. To normalize
compound activity in relation to plate-to-plate variations in the assay signal, and to calculate Z’-
factors, Control Plates containing also 10 μMAmpB and the vehicle 1% DMSO (in alternating
fashion) were also included [30]. The quality of the assay was given by Z’ factor that was calculat-
ed as 1 –[(3SD positive controls + 3SD negative controls) / (mean of the positive controls–mean
of the negative controls)]. Data from plates were used only if Z’ factors were> 0.5 [31]. Primary
hits were defined as compounds displaying 60% inhibition of signal readout.
Assessment of cell toxicity (CC50)
To test the toxicity of the identified hit compounds we established splenic ex vivo explant cultures
of uninfected BALB/c mice. Briefly, the animals were euthanized and the spleens were aseptically
Infrared Fluorescent Imaging in Visceral Leishmaniasis
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removed and homogenized as described above. The cell suspension culture was conducted in
RPMI medium, 10% FCS, 1 mM sodium pyruvate, 1x RPMI vitamins, 10 mMHEPES and
100 U/ml penicillin and 100 μg/ml streptomycin. Cells were microscopically counted and distrib-
uted into clear 96-well plates; 50 μl of uninfected splenocytes were added to each well (5 x 105
cells), containing 50 μl of serial 2-fold dilutions of the test compounds (200–0.1 μM) or the
DMSO control. After 72 h of incubation at 37ºC and 5% CO2, the viability of the cells was as-
sessed using the Alamar Blue assay according to manufacturer’s recommendations (Invitrogen).
In vivo fluorescence imaging of infrared L. infantum infected BALB/c
mice
Mice infected with wild type and HSP70+L. infantum parasites were imaged using an intensi-
fied charged coupled device camera of the In Vivo Imaging System (IVIS 100, Xenogen). To
minimize background when imaging in the near infrared, the normal diet was replaced by a
purified diet during 7 days (AIN-93M, LabDiet, UK), since chlorophyll fluoresces naturally,
emitting between 675 and 685 nm, and is detected in the 700 nm channel. Nevertheless, ani-
mals were fasted overnight, although water was allowed freely before acquiring the images in
order to assure that faeces were removed from intestines. The animals were shaved to reduce
background signal due to the fur. The animals were then lightly anesthetized with 2.5–3.5% iso-
flurane (then reduced to 1.5–2.0%), placed in the camera chamber, and the fluorescence signal
was acquired for 1 s. Fluorescence determinations, recorded by the IVIS 100 system, were ex-
pressed as a pseudocolour on a grey background, with yellow colour denoting the highest in-
tensity and dark red the lowest one.
Results
Generation and characterization of infrared-L. infantum strains
Aimed to create stably-integrated infrared L. infantum BCN 150 strains we electroporated
wild-type promastigotes with the lineal 6156 and 6110 bp SwaI-SwaI fragments containing the
ORFs encoding IFP 1.4 and iRFP, respectively, as well as the selection marker of the pLEXSY-
hyg2 plasmid. We will refer to them as IFP 1.4+L. infantum and iRFP+L. infantum. After selec-
tion on semisolid plates containing 200 μg/ml hygromycin B, individual colonies were seeded
in M199 liquid medium supplemented with 10% FCS and hygromycin B. Genomic DNA iso-
lated from these cultures was used to confirm the correct integration of the target sequence
into the 18S rRNA locus of L. infantum genome (data not shown).
Fig. 1A shows that the genomic manipulation of the engineered strains did not affect the
growth rate of the parasites compared to wild-type promastigotes. Further comparative studies
aimed to characterize the two infrared strains were performed. In order to measure the fluores-
cence emission of both strains, we employed logarithmic promastigotes of IFP 1.4+L. infantum
and iRFP+L. infantum (Fig. 1B), as well as intracellular amastigotes isolated from infected
THP-1 cells in vitro (Fig. 1C), and lesion-derived amastigotes obtained from infected spleens of
BALB/c mice at 5 wpi (Fig. 1D). A clear positive correlation was observed between the fluores-
cence signal and the number of logarithmic promastigotes placed in 96-well plates (Fig. 1B).
Surprisingly, intracellular parasites expressing both infrared reporters (1C and 1D) displayed
higher differences than promastigote cultures. All results clearly showed the superior fluores-
cence signal of the iRFP protein over IFP1.4, particularly at the really relevant stage of the para-
site life cycle, the amastigotes, both isolated from THP-1 macrophages and from lesions.
Moreover, the stability of iRFP expression was monitored over a period of 6 months after
Infrared Fluorescent Imaging in Visceral Leishmaniasis
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transfection and no change was observed in fluorescence intensity during this period, even in
the absence of hygromycin B (Fig. 1B).
Construct optimization
Once the iRFP reporter was chosen, we optimized the expression by replacing the original utr2
from pLEXSY-hyg2 vector with three sequences containing both 3’UTRs and IR (we will refer
Fig 1. Infrared IFP1.4 and iRFP genes are functionally expressed in L. infantum parasites. A) Growth rate of wild-type (WT;▲) and stably-modified
promastigotes IFP1.4+L.infantum (●) and iRFP+L.infantum (). Parasites were counted using a Coulter counter. B) Correlation between fluorescence signal
expressed as arbitrary units (AU) and the number of logarithmic IFP1.4+L. infantum (●) and iRFP+L. infantum () promastigotes in the presence of
hygromycin B or after 6 months culture without drug IFP1.4+L. infantum (▲), iRFP+L. infantum (Δ). Two-fold serial dilutions were applied. C) Flow-cytometry
analysis of intracellular amastigotes isolated from THP-1 in vitro infections with IFP1.4+L. infantum (red) and iRFP+L. infantum (green) strains. D) Mean
fluorescence intensity emitted by lesion-derived amastigotes obtained from the engineered parasites. Experiments were carried out with 107 parasites by
triplicate and error bars represent standard deviations. Significance level *** p< 0,001; ** p<0.01; from two tails of Student t-test.
doi:10.1371/journal.pntd.0003666.g001
Infrared Fluorescent Imaging in Visceral Leishmaniasis
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to as downstream regions, DSR). Two of these DSR belong to stage-regulated genes in the
amastigote stage, the A2 and AMASTIN genes [23, 24]. The third DSR belongs to the HSP70 II
gene of L. infantum, a sequence involved in mRNA stability at 37ºC [25]. Fig. 2A shows the
schematic view of the different constructs containing the iRFP reporter gene.
Fig 2. Optimization of pLEXSY-iRFP vector by introducing downstream regions (DSR) of different genes. A) Schematic view of pLEXSY-hyg2
constructs containing infrared (iRFP) reporter gene and different DSR corresponding to A2, AMASTIN andHSP70-II genes. Constructs were linearized by
SwaI digestion prior to electroporation. B) Correlation between fluorescence signal and the number of logarithmic promastigotes modified with iRFP-
pLEXSY-HYG (□) or carrying the DSR of A2 (●), AMASTIN () or HSP70-II (Δ) genes. C) Flow-cytometry analysis of intracellular amastigotes isolated from
THP-1 in vitro infections. D) Mean fluorescence intensity emitted by lesion-derived amastigotes obtained fromWT and the engineered parasite strains
carrying iRFP. Experiments were carried out with 107 parasites by triplicate and error bars represent standard deviations (SD). Significance level
*** p< 0,001; ** p<0.01; from two tails of Student t-test.
doi:10.1371/journal.pntd.0003666.g002
Infrared Fluorescent Imaging in Visceral Leishmaniasis
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In a similar way to IFP 1.4 and iRFP-expressing parasites, we proceeded to compare the
fluorescent signal of iRFP+, A2+, AMASTIN+ and HSP70+L. infantum strains. A clear correla-
tion between the fluorescence emission and the number of parasites was also detected by using
logarithmic promastigotes (Fig. 2B). Interestingly, replacement of the utr2 from pLEXSY vector
with the corresponding DSR sequences from the A2 and AMASTIN genes resulted in a reduc-
tion of the fluorescent levels in the promastigotes. However, using the same strains but isolat-
ing the intracellular amastigote stage, from both infected THP-1 cultures (Fig. 2C) and lesions
(Fig. 2D), we observed a 2–2.5-fold increase in fluorescence emission. Nevertheless, the most
significant increase (p<0.001) was obtained with amastigotes carrying the plasmid including
HSP70 II as DSR.
Characterization of a VL murine model with HSP70+L. infantum
Infection of laboratory mice with either L. infantum or L. donovani vary markedly between dif-
ferent organs. In the liver, the infection can resolve, unlike in the spleen, where Leishmania
parasites may persist [32]. Therefore, we established a model of visceral L. infantum infection
that allowed us to collect large numbers of naturally-infected cells from spleen to use as ex vivo
explant. Infected mice were euthanized at different times post-infection. The spleens were
weighed, processed to obtain a cellular suspension culture and the burden parasite and the pro-
liferative response of mouse spleen cells were evaluated. There was a dramatic increase in
spleen size, up to 1.0 g (Fig. 3A), splenocyte culture, (up to 12 x 108 cell/spleen, Fig. 3B), and
parasite burden (up to 25 x 106/100 mg tissue, Fig. 3C), whereas the proliferative response
dropped to basal levels at five wpi (Fig. 3D). Consequently, for drug screening we established
five wpi as the time point for the ex vivo splenic explant culture. Finally, to be sure that fluores-
cence signal was stable in infected animals throughout all this time, parasites from infected
spleens were also isolated and amastigote standard curves were prepared at 3, 4 and 5 wpi
(Fig. 3E). As previously described by other authors, the loss of fluorescent signal during the
evaluated period of time was not significant [18, 33]. In addition, the amastigote standard
curves provided us the number of amastigotes that were used during the screening assays.
Establishment and optimization of the ex vivo explant culture
Firstly, we checked the fluorescence dynamic range in which we could assure the effective and
quantifiable replication of intracellular parasites inside macrophages in the absence of active
drug over the course of the ex vivo culture. However, since there were individual-to-individual
differences in parasite load, we first needed to establish the appropriate starting cell-density
well that allowed the detection of parasite proliferation. For this purpose, we fixed the fluores-
cence level per well, instead of adjusting the number of cells. We followed the replication of the
amastigotes within the splenic culture each 24 h during 5 days, using four different starting
densities ranging from 0.25 x 105 to 2.0 x 105 arbitrary units (AU). The signal was measured in
black 384-well plates with clear bottom using the infrared imager Odyssey (LI-COR). After 5
days of culture, only those wells containing 2.0 x 105 AU at the beginning of the assay sup-
ported the active replication of the parasite in the absence of active drug over the whole experi-
ment, indicating ongoing multiplication of the amastigote cells (Fig. 4A).
The next step was to assure that the selected starting cell density was accurate to guarantee
the correct discrimination between drug-treated and untreated control wells. For doing this,
different concentrations of AmpB (20, 6.6, 2.2, 0.74 μM) were added to the explant and the re-
duction in parasite load was measured by quantifying the loss of infrared fluorescence for 72 h
(Fig. 4B). To confirm these results, and also to establish the AmpBEC100, as well as the appropri-
ate period of incubation, ten serial 2-fold AmpB dilution steps covering a range from 10 to
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Fig 3. Establishing the appropriate time for ex vivo splenic explant culture.Mice infected with 107 metacyclic-engineered HSP70+L. infantum strain
were evaluated from 21 to 35 days post infection (n = 6 per time point). A) Spleen weight (shown as the mean ± SD). B) Splenocyte number obtained from a
single animal was determined by counting the cells by direct microscopy (mean ± SD). C) Splenic parasite burden. Parasitic load expressed as LDAU after
ten days of differentiation of amastigotes into promastigotes (left axis). The number of amastigotes (mean ± SD) was determined by fluorescent emission of
splenocytes (10 mg of splenic cellular suspension) extrapolating to the standard curve (right axis) D) Splenocyte stimulation index expressed as the ratio
ConA-stimulated and non-stimulated splenocytes (shown as the mean ± SD). E) Amastigote standard curve; correlation between fluorescent signal and
number of amastigotes counted by microscopy. Significance level *** p< 0,001; ** p<0.01; from two tails of Student t-test.
doi:10.1371/journal.pntd.0003666.g003
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Fig 4. Establishing conditions for using the splenic explant culture as drug screening platform in 384-well plates. A) Starting cell density-well.
Splenocytes were plated at different fluorescent signals (four 2-fold dilutions from 2.0 x 105arbitrary units (AU) and incubated at 37ºC and 5%CO2 for 5 days.
Each 24 h the fluorescent signal was read in an Odyssey1 infrared imager (LI-COR). B) Effect of AmpB on splenocyte culture. Four 3-fold dilutions from
20 μMAmpB were added to splenic explant cultures at 2.0 x 105 starting density-well. Fluorescence emission was recorded each 24 h during 3 days of
incubation. C-E) AmpB dose-response profile. Splenocytes were plated at different starting densities and incubated in presence of ten 2-fold dilutions from
10 μM concentration. Fluorescence signal was recorded for 96 h. IC50 values were calculated after a nonlinear fitting with the SigmaPlot software. F) Infrared
fluorescence recording of a representative 384-well plate in the infrared imager Odyssey (LI-COR). G) Giemsa staining of macrophages infected with HSP70
+L. infantum 24 and 72 h after culturing. Experiments were carried out by triplicate and error bars represent standard deviations (SD).
doi:10.1371/journal.pntd.0003666.g004
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0.02 μMwere assayed against three starting cell densities (from 1.0, 2.0 and 4.0 x105 AU).
Readouts were harvested at 72 and 96 h. Surprisingly, IC50 values at 72 h were very similar in
all the starting cell densities, ranging between 0.27–0.38 μM, (Fig. 4C-E) which corresponded
with data collected by other authors [10, 34]. These results suggest that all these conditions
allow the screening of compounds. To confirm the quality of the assay in discriminating active
from inactive compounds, we calculated the Z prime (Z’) factor in 3 different screening experi-
ments using 6 different plates. All Z’ were higher than 5.0, which demonstrated the correct re-
producibility and the suitable quality of the assay [31].
Fig. 4F shows the fluorescence image of a 384-well plate containing the ex vivo culture treat-
ed with different compounds, where the red colour shows different intensities, which reflects
the viability of the amastigotes in each well. The course of the ex vivo infection was followed
over a period of 72 h by measuring the absolute fluorescence of the infection and the percent-
age of infected macrophages by classical Giemsa staining to determine parasite load (data not
shown, Fig. 4G). No differences between both methods were accounted, thus pointing to the
suitability of fluorescence analyses to assess the infectivity of HSP70+L. infantum strain on
mouse macrophages.
Moreover, intracellular forms were analyzed by confocal microscopy at 633 nm, after 5 wpi. A
strong red fluorescence emission from round-shaped HSP70+L. infantum-emitting amastigotes
was observed inside parasitophorous vacuoles in the cytoplasm of the infected macrophages
(Fig. 5), confirming that the fluorescent signal was not lost during the ongoing proliferation of
intracellular amastigotes.
Screening of a 295-compound library
A library of 295 compounds comprising three collections of chemically distinct structures was
screened at a concentration of 10 μM. The threshold for selecting hits was set as inhibitory ac-
tivity of 60% after 3 independent assays. Twenty-four primary hits were obtained out of the
295 compounds (8%). Our next goal was to select, amongst the 24 confirmed hits, the best can-
didates for further investigation. Firstly, compounds were tested in dose-response curves using
7–8 concentrations 2-fold diluted from 50 μM, 100 mM and 2.5 mM respectively for combres-
tatins, carbolins and indenoisoquinolins. Then, the cytotoxicity of these compounds was tested
in different concentrations with a 3-day assay on non-infected ex vivo explant cultures (CC50)
using Alamar Blue (data not shown). Five out of the 24 hits were selected based on a threshold
of Selective Index (SI = CC50/IC50), score of30. They included combrestatins (8%; 2/24), car-
bolins (8%; 2/24) as well as indenoisoquinolines (4%; 1/24) (Table 2).
Appraisal of L. infantum in vivo infection by infrared fluorescence
imaging
Finally, the applicability of theHSP70+L. infantum for imaging in BALB/C mouse was tested.
Animals (n = 10) were inoculated intraperitoneally with 107 stationary-phase HSP70+L. infan-
tum promastigotes. The mice were imaged at 0, 10 and 20 wpi. A bright and intense signal was
detected after parasite injection allowing even to trace the needle entry site. The transitory he-
patic episode (14 days post-infection) was out of the scope of this experiment. On the contrary,
spleen colonization was evidenced after 10 wpi and until the end of the experiment (Fig. 6A).
Five animals were euthanized and after removal of the overlying skin (Fig. 6B top) and perito-
neum (Fig. 6B down), increasing fluorescence signal was detected, confirming the above-
mentioned results. The dissected organs were entirely fluorescent (Fig. 6C). Because of a lower
parasite burden in the hepatic organ, the high level of fluorescence emitted by amastigotes in
the spleen might have blocked the detection of parasites in the liver when imaging both organs
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at the same time. In order to tackle a future drug trial in vivo, the appraisal of infection was
monitored for up to 2 wpi, showing that the fluorescent signal was still visible in the remaining
group of mice (Fig. 6A). These results support future long-treatment schedules to tackle in vivo
drug trials against VL.
Table 2. IC50 and CC50 of selected hits.
Compound IC50 (μM) CC50(μM) SI = CC50/IC50
Combrestatin 1 0,12 ± 0,0013 4,33 ± 0,49 33,7
Combrestatin 2 0,071 ± 0,0033 2,65 ± 0,21 37,3
Carbolin 1 1,44 ± 0.05 >200 138
Carbolin 2 5,24 ± 0.26 >200 38
Indenoisoquinoline 0,0113 ± 0,0019 0,33 ± 0,050 30
SI: Ratio of CC50 to IC50. Data are displayed as mean ± SD of three independent experiments.
doi:10.1371/journal.pntd.0003666.t002
Fig 5. Confocal microscopy analysis of splenic explants infected with HSP70+L. infantum amastigotes. A) Differential Interference Contrast (DIC). B)
HSP70+L. infantum emitting infrared fluorescence. C) DAPI staining of nucleic acids. D) Merged images. Microscopy images were acquired with a Zeiss
LSM710 confocal microscope.
doi:10.1371/journal.pntd.0003666.g005
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Discussion
In this work we present a potent tool based on infrared fluorescent proteins to achieve a double
goal; on the one hand a robust platform for HTS screening of compounds and on the other
hand an in vivo imaging of visceral Leishmania infections. Firstly, we chose between two differ-
ent sources of infrared fluorescent proteins (Deinococcus radiodurans and Rhodopseudomonas
palustris) [21, 22], and then we optimised the expression level by introducing different DSR of
well-known virulence factors and heat shock proteins.
Initially, we compared the suitability of two fluorescent infrared stably-modified strains, in
terms of brightness and fluorescence-emission properties in promastigotes and amastigotes of
L. infantum BCN 150. iRFP+L.infantum reached significantly higher emission than IFP1.4+L.
infantum throughout the different stages of L. infatnum life cycle. Fluorescent levels varied 2–3
times between both strains, and allowed the detection of as little as 100 intracellular amasti-
gotes. In general, the intracellular stage has a lower emission due to their low metabolism, a
fact that has been previously pointed out by other authors [35, 36]. Unlike other fluorescent
Fig 6. Monitoring the course of the in vivo visceral infection. A) In vivo imaging of BALB/c mice (n = 10) infected with 107 metacyclic promastigotes of
HSP70+L.infantum after 10 (three top) and 20 (three bottom) wpi. B) Mice (n = 5) were euthanatized and dissected, and the infrared signal was acquired after
removal of skin and after removal of overlying peritoneum, showing internal organs after 10 wpi. C) Infrared fluorescence emission from a representative
spleen (left) and liver (right) isolated from infected mice.
doi:10.1371/journal.pntd.0003666.g006
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reporters whose emission wavelengths are in the visible spectrum, near infrared fluorescent
proteins have improved optical properties since the absorbance of haemoglobin, protein and
lipids, as well as light-scattering, is minimal [21]. Thereafter, optimization of the vector was
achieved by including different sequences; two of them previously described as virulence fac-
tors [23, 24], and the third one having a protection role against heat and oxidative stress in VL
[25]. The highest levels of expression were associated with HSP70+L. infantum, which contains
the downstream sequences from HSP70-II gene, with influence on transcript stability at condi-
tions that facilitate the survival of the parasites within mammalian hosts [37]. Furthermore, the
fluorescence emission of this reporter has been enhanced via stable integration into 18S rRNA
locus, which represents an efficient and effective strategy that enables expression of proteins,
avoiding the need of drug selection for both in vitro screenings and in vivo infections as previ-
ously described [17, 18, 35, 38, 39, 40, 41, 42].
Once the tool was selected, its applicability for drug discovery in VL in terms of searching
new hits was assessed. Leishmania represents an enormous challenge as an intracellular para-
site, since the drug must kill the parasite without affecting the host cells. Recently, HCS using
image-based microscopy have been proposed as a robust platform for evaluating intracellular
infections [10, 36]. In this system, axenically parasite cultures are used to infect macrophage’s
cell lines. However, this approximation has several drawbacks: i) it is highly complex, ii) axenic
parasites have notable differences with amastigotes [43], and when they have been used in
screening assays a high false-positive rate was associated [36], and iii) the use of macrophage
lines as host cell has also been questioned [34].
A novel approach based on the physiological and immunological environment of the infec-
tion site has been proposed [29]. Ex vivo explant is a primary culture that contains the full vari-
ety of cells that allow the parasite progression in the infected organ, and not only inside
macrophages. Moreover, the infection is not recently established, but installed several weeks
before the addition of the drug and the evaluation of its effect, and thus it greatly resembles
human infections. From the lab point of view, the manipulation is minimal and a large number
of test wells are easily prepared from a single infected animal.
In this work, the ex vivo splenic explant used for drug screening was developed in BALB/c
mice infected with L. infantum, showing the typical features of VL with enlargement of spleens,
high parasite burden, and loss of proliferation in splenic cells. The system congregates the basic
rules previously defined for drug-screening systems for trypanosomatids [44]. i) it uses dividing
populations of the mammalian stages of the parasite, ii) the drug activity is readily quantified by
changes in infrared fluorescence signal, iii) a standard drug for VL (AmpB) showed activity at
concentrations near to the one reached in serum [45, 46]. A crucial point was to establish the
signal discrimination referred to the number of amastigotes in the infected cells per well.
The system was assessed with a selected set of compounds coming from three different col-
lections and well-known active drugs were also included. The system adaptation presented
here, allows for rapid identification of active compounds without the requirement of substrate
reagents to get the readouts, and hence, the cost is reduced compared to other systems. The
model uses a stable-modified Leishmania with no significant loss of reporter signal after more
than 20 wpi. The fluorescence signal of the infected splenic explant has lineal correlation with
the number of amastigotes, which makes the system easily adaptable to quantitative assays.
Furthermore, there is no need of expensive infrastructure, such as the HCS, which are not af-
fordable for some labs. Since the assay could be performed in 384-well plates, a single infected
animal could be enough to screen more than 500 compounds.
However, host factors involved in the pharmacokinetics and pharmacodynamics of drugs
are out of the scope of in vitro drug screening, consequently in vivo drug assays are still neces-
sary. Using the same tool, parasite dissemination in an in vivo chronic model of VL has been
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traced for the first time based on infrared fluorescence signal. At 5 wpi, the animals were im-
aged, but not clear fluorescence signal was recorded. After 10 wpi an undisputed infrared signal
was achieved, showing that the splenomegaly had been already established time before.
Many studies initiate drug administration trials after one or two weeks post-infection assess-
ing the effect against the liver infection time with a peak in the parasite burden [47]. However,
our goal was to use this model for longer times in order to perform future drug administrations
against spleen infection, so the animals were pictured after 20 wpi and the fluorescence signal
was still strongly detected. Therefore, this in vivo imaging model could be used without signifi-
cant loss of reporter emission, allowing the appraisal of chronic infections after
drug treatments.
In conclusion, the near-infrared fluorescent L. infantum strain used in the current work rep-
resents an important step forward in bioimaging research of VL, providing a robust model of
phenotypic screening suitable for HTS of collections or libraries of small molecules in the
amastigote form of mouse splenic explants. In addition, this novel L. infantum strain could be
used in preclinical in vivo studies of potential lead compounds against visceralizing Leishmania
species.
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